Newleos Therapeutics Secures $93.5M Series A to Advance CNS Drug Development
Key Highlights Newleos Therapeutics secures $93.5 million in Series A funding, led by Goldman Sachs Alternatives, with participation from Novo Holdings A/S,…
Browsing Tag
DCVC Bio
5 posts
Radionetics Oncology Forms Strategic Relationship with Eli Lilly
Key Highlights Radionetics Oncology receives $140 million upfront cash payment. Eli Lilly secures exclusive acquisition rights for $1…
Avicenna Biosciences Enhances ML Tech for Drug Discovery
Key Highlights $14.5 Million Raised: Seed funding led by DCVC Bio to advance clinical-stage drug discovery. Innovative Collaboration: Research with…
Latus Bio Launches with $54M for CNS Gene Therapies
Key Highlights $54 million Series A financing led by 8VC and DCVC Bio. Focus on gene therapy candidates for CLN2…
Solu Therapeutics Appoints Dr. Philip J. Vickers as New CEO
Solu Therapeutics, a precision-medicine company, announces the appointment of Dr. Philip J. Vickers as its new President and…